Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Cohance Lifesciences Limited (NSE: COHANCE), ISIN INE03QK01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
COHANCE last traded at ₹461.55 (+2.02%), with a 52-week range of ₹267.85 to ₹917.50 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 57.49%, FIIs 6.50%, DIIs 20.09%, mutual funds 18.21%.
EquiSense Score (ECS): 25/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.